Related Experiment Videos

Possibilities for the pharmacological exploitation of ischaemic preconditioning

¹Department of Physiology and Pharmacology, University of Strathclyde, Glasgow, UK.

Journal of Molecular and Cellular Cardiology

|April 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart.

Archives of pharmacal research·2006

Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs.

Cardiovascular drugs and therapy·2000

Isosorbide-2-mononitrate reduces the consequences of myocardial ischaemia, including arrhythmia severity: implications for preconditioning.

Cardiovascular drugs and therapy·2000

The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.

British journal of pharmacology·2000

Coronary vascular endothelium-myocyte interactions in protection of the heart by ischaemic preconditioning.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2000

Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.

European journal of pharmacology·1999

See all related articles